Loading clinical trials...
Loading clinical trials...
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy and Safety of Bupivacaine TTS (Bupivacaine Patch) in Patients With Chronic Low Back Pain
Conditions
Interventions
Bupivacaine TTS (Bupivacaine Patch)
Placebo patch
Locations
21
United States
Tempe, Arizona, United States
La Mesa, California, United States
Torrance, California, United States
Fort Lauderdale, Florida, United States
Gainesville, Florida, United States
Longwood, Florida, United States
Start Date
March 1, 2010
Primary Completion Date
February 1, 2011
Completion Date
February 1, 2011
Last Updated
June 15, 2022
NCT03836248
NCT07132762
NCT06419439
NCT06384001
NCT07163117
NCT06630676
Lead Sponsor
Durect
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions